Tag Archives: Prescribing
Fluticasone Improves Histologic Eosinophilia in Esophagitis – Monthly Prescribing Reference
(HealthDay News) — Swallowing aerosolized fluticasone improves histologic eosinophilia but does not improve dysphagia symptoms in adults with eosinophilic esophagitis (EoE), according to a study published online in the July issue of Clinical … Bing News – Full Story →
Phase 3 Study Update of Epanova for Hypertriglyceridemia – Monthly Prescribing Reference
Omthera Pharmaceuticals announced the results from EVOLVE, the Phase 3 study of Epanova for treatment of patients with very high triglycerides. Epanova met the study’s primary endpoint by significantly reducing triglycerides in all dose groups, with median … Bing News … Continue reading
Office-Related Antibiotic Prescribing for Persons Aged ≤14 Years—United States, 1993-1994 to 2007-2008 – AMA
Among the five acute respiratory infections (ARIs) examined, antibiotic prescribing rates decreased 26% for pharyngitis and 19% for nonspecific upper respiratory Bing News – Full Story →
Methylnaltrexone Demonstrates Long-Term Relief of Opioid-Induced Constipation – Monthly Prescribing Reference
Study endpoints include the percentage of injections resulting in a bowel movement within 4 hours and the change from baseline in the number of weekly bowel movements. Additional assessments included Bristol Stool Form, Straining, and Evacuation Scales. Bing News – … Continue reading
Extended Dosing Interval for Somatuline Depot Injection Approved – Monthly Prescribing Reference
The FDA has approved revised labeling to include an extended dosing interval of Somatuline Depot (lanreotide; Ipsen) Injection for the treatment of acromegaly. The updated dosing recommendations allow patients with acromegaly currently controlled on … Bing News – Full Story … Continue reading
